Skip to main content

ENvue Medical, Inc.

corporate_fare Company Profile

ENvue Medical, Inc.

FEED·NASDAQ·Industrial Applications And Services·CIK 0001326706

ENvue Medical, Inc. is a medical device company that operates through two wholly-owned subsidiaries. The company was incorporated in Delaware in October 2003 and changed its name from NanoVibronix, Inc. to ENvue Medical, Inc. in December 2025. This name change followed a merger completed on February 14, 2025. One subsidiary, NanoVibronix Ltd. ("Nano OpCo"), is a private company incorporated under the laws of the State of Israel. Nano OpCo focuses on non-invasive medical devices that activate biological responses. These devices are designed for home use without requiring medical professional assistance and target biofilm prevention and pain therapy. The second subsidiary, ENvue Medical Holdings LLC, is a Delaware limited liability company. This entity is a medical device company involved in the research, development, production, marketing, and sale of medical devices for enteral feeding. This division is currently in the initial growth stage of commercialization.

ENvue Medical, Inc. (NASDAQ:FEED) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 27 items for FEED at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Major Shareholder's Stake Diluted from 22.1% to 6.5% Due to Company Share Issuance
  • Annual Report Reveals Substantial Doubt on Going Concern, Massive Losses, and Arbitration Judgment Exceeding Market Cap
  • ENvue Medical Expands Footprint to 39 U.S. Hospitals with Major Michigan Health System Deal
  • 10% Owner Christian Michael Glibert Makes Substantial $640K Open Market Purchase
  • New Investor Christian Glibert Discloses 22.05% Stake in ENvue Medical

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.55M
Net Income
-$18.18M
Diluted EPS
-$26.69
Op. Cash Flow
-$9.37M
Free Cash Flow
-$9.43M
Gross Profit
$153K
Operating Income
-$22.89M
Cash & Equivalents
$4.22M
Debt / Equity
0.00×
Net Margin
-7.12×
Shares Outstanding
1.1M sh
Source: 10-K · filed 2026-04-15 · accession 0001493152-26-016871
$3.48 -0.10% today
52-week range · as of 2026-08-31 $0.29 – $17.4
Market cap
$3.21M
Volume
13.4K (0.1× avg)
3-mo avg 119.8K
Live data · 2026-09-14 17:27 UTC · Market open

show_chartPrice Chart

Loading chart...

feed FEED - Filings & News (Page 2)

FEED
Apr 17, 2026, 4:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
FEED
Apr 15, 2026, 5:19 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.67
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
FEED
Mar 24, 2026, 8:07 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.77
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
FEED
Feb 11, 2026, 6:52 PM EST
Filing Type: 4
Importance Score:
9
Price at Filing: $2.75
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
FEED
Feb 11, 2026, 6:22 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $2.71
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
FEED
Feb 06, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.93
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
FEED
Jan 30, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.00
Real-time Price: $3.48 info
Change: Reverse Stock Split info
Market Cap: $3.21M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets